MXPA02006610A - Sustancias para uso al tratar psoriasis. - Google Patents

Sustancias para uso al tratar psoriasis.

Info

Publication number
MXPA02006610A
MXPA02006610A MXPA02006610A MXPA02006610A MXPA02006610A MX PA02006610 A MXPA02006610 A MX PA02006610A MX PA02006610 A MXPA02006610 A MX PA02006610A MX PA02006610 A MXPA02006610 A MX PA02006610A MX PA02006610 A MXPA02006610 A MX PA02006610A
Authority
MX
Mexico
Prior art keywords
substances
treating psoriasis
psoriasis
diacerein
manufacture
Prior art date
Application number
MXPA02006610A
Other languages
English (en)
Inventor
Napoli Guido Di
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Publication of MXPA02006610A publication Critical patent/MXPA02006610A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe el uso de diacereina o un derivado farmaceuticamente aceptable de la misma para la fabricacion de una composicion farmaceutica para el tratamiento de psoriasis o enfermedades asociadas con la misma, tal como artritis psoriatica.
MXPA02006610A 2000-01-12 2001-01-08 Sustancias para uso al tratar psoriasis. MXPA02006610A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH532000 2000-01-12
PCT/IB2001/000005 WO2001051044A2 (en) 2000-01-12 2001-01-08 Substances for use in treating psoriasis

Publications (1)

Publication Number Publication Date
MXPA02006610A true MXPA02006610A (es) 2004-09-10

Family

ID=4291590

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02006610A MXPA02006610A (es) 2000-01-12 2001-01-08 Sustancias para uso al tratar psoriasis.

Country Status (22)

Country Link
US (2) US6844365B2 (es)
EP (1) EP1248608B1 (es)
JP (1) JP4912554B2 (es)
CN (1) CN1187045C (es)
AR (1) AR026801A1 (es)
AT (1) ATE254913T1 (es)
AU (1) AU776324B2 (es)
BR (2) BRPI0107493B8 (es)
CA (1) CA2396111C (es)
CZ (1) CZ301129B6 (es)
DE (1) DE60101309T2 (es)
DK (1) DK1248608T3 (es)
ES (1) ES2210120T3 (es)
IL (2) IL150390A0 (es)
MX (1) MXPA02006610A (es)
PL (1) PL212010B1 (es)
PT (1) PT1248608E (es)
RU (1) RU2266740C2 (es)
SK (1) SK286589B6 (es)
TR (1) TR200400228T4 (es)
WO (1) WO2001051044A2 (es)
ZA (1) ZA200205148B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (zh) * 2002-12-30 2007-06-20 北京大学第一医院 大黄酸在抑制血管生成中的应用
NZ591701A (en) 2005-05-16 2012-11-30 Abbott Biotech Ltd Use of tnf inhibitor for treatment of erosive polyarthritis
WO2008063213A2 (en) * 2006-04-10 2008-05-29 Abbott Biotechnology Ltd. Uses and compositions for treatment of psoriatic arthritis
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
ES2560310T3 (es) * 2010-04-08 2016-02-18 Twi Biotechnology, Inc. Métodos de uso de diacereína como una terapia concomitante para diabetes
WO2017123672A1 (en) * 2016-01-12 2017-07-20 Lawrence Chan Combination treatment for inflammatory diseases
CN106236729A (zh) * 2016-07-31 2016-12-21 合肥远志医药科技开发有限公司 一种双醋瑞因胶囊制剂及其制备方法
CN106692109A (zh) * 2017-01-02 2017-05-24 佛山市腾瑞医药科技有限公司 一种微孔膜控释包衣双醋瑞因微丸及其制备方法
KR102563841B1 (ko) * 2017-01-19 2023-08-03 티더블유아이 바이오테크놀로지 인코포레이티드 면역염증성 피부 장애를 예방 또는 치료하기 위한 방법 및 약학적 조성물
CN106667954A (zh) * 2017-02-14 2017-05-17 佛山市腾瑞医药科技有限公司 一种双醋瑞因软胶囊制剂及其制备工艺
CN106619555A (zh) * 2017-02-14 2017-05-10 佛山市腾瑞医药科技有限公司 一种双醋瑞因速释微丸制剂、制备方法
CN106727360A (zh) * 2017-02-16 2017-05-31 佛山市腾瑞医药科技有限公司 一种双醋瑞因固体分散体制剂及其制备方法
AU2019245521A1 (en) * 2018-03-29 2020-11-12 S.I.S Shulov Innovative Science Ltd. Pharmaceutical compositions for inhibiting inflammatory cytokines
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN112755013A (zh) * 2021-02-22 2021-05-07 北京市中医研究所 大黄酸作为s100a8的抑制剂在炎症性疾病中的制药应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1264545B1 (it) 1993-07-30 1996-10-02 Medidom Lab Procedimento per la preparazione della diacereina
IT1282381B1 (it) 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
IT1283771B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
IT1283772B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) * 1996-10-18 2007-12-05 正規 小菅 津液改善用皮膚外用剤
JPH10129556A (ja) 1996-10-28 1998-05-19 Fumiaki Mori 盗難防止自転車
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
IT1297038B1 (it) 1997-12-30 1999-08-03 Medidom Lab Procedimento per la preparazione di reina e suoi diacilderivati

Also Published As

Publication number Publication date
RU2266740C2 (ru) 2005-12-27
SK286589B6 (sk) 2009-01-07
ATE254913T1 (de) 2003-12-15
US20050004045A1 (en) 2005-01-06
US20020143057A1 (en) 2002-10-03
AU2213201A (en) 2001-07-24
PL212010B1 (pl) 2012-07-31
BRPI0107493B8 (pt) 2021-05-25
WO2001051044A2 (en) 2001-07-19
CZ301129B6 (cs) 2009-11-11
CZ20022382A3 (cs) 2002-11-13
AU776324B2 (en) 2004-09-02
WO2001051044A3 (en) 2002-03-28
TR200400228T4 (tr) 2004-02-23
AR026801A1 (es) 2003-02-26
EP1248608B1 (en) 2003-11-26
JP2003519653A (ja) 2003-06-24
SK9912002A3 (en) 2003-02-04
JP4912554B2 (ja) 2012-04-11
BRPI0107493B1 (pt) 2019-04-16
DE60101309T2 (de) 2004-09-16
US6844365B2 (en) 2005-01-18
BR0107493A (pt) 2002-10-08
PT1248608E (pt) 2004-04-30
IL150390A (en) 2007-07-24
DE60101309D1 (de) 2004-01-08
ZA200205148B (en) 2003-06-26
EP1248608A2 (en) 2002-10-16
IL150390A0 (en) 2002-12-01
CN1187045C (zh) 2005-02-02
ES2210120T3 (es) 2004-07-01
CN1395484A (zh) 2003-02-05
CA2396111A1 (en) 2001-07-19
DK1248608T3 (da) 2004-04-05
PL356784A1 (en) 2004-07-12
CA2396111C (en) 2008-12-02

Similar Documents

Publication Publication Date Title
MXPA02006610A (es) Sustancias para uso al tratar psoriasis.
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
HUP0204399A3 (en) Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use
AU7031500A (en) Therapeutic quinazoline compounds
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
YU31801A (sh) Amidi antranilne kiseline i njihova upotreba kao leka
MXPA04005376A (es) Composiciones farmaceuticas y sus usos.
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
DE60015508D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
AU4080097A (en) Piperazino derivatives as neurokinin antagonists
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
GB9907571D0 (en) Compounds
MXPA05001469A (es) Uso de extracto de germen de trigo fermentado como agente anti-inflamatorio.
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
PT907737E (pt) Muteina da il-6
AU2003255429A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
UA33498A (uk) Спосіб лікування терапевтично резистентних форм шизофренії
HN1999000145A (es) Uso de compuestos analogos a 1.3 oxatiolano-nucleosidos en la fabricacion de un medicamento para el tratamiento de la hepatitis b.

Legal Events

Date Code Title Description
FG Grant or registration